Newest IDSA Guidance Pertains to AmpC-Bearing Gram-Negative Pathogens
A panel recently re-convened recently to develop guidance for AmpC-bearing gram-negative pathogens.
In an interview with Pharmacy Times, Thomas Lodise, PharmD, PhD, discussed new guidance released by the Infectious Diseases Society of America (IDSA) on the treatment of antimicrobial resistant gram-negative infections. The guidelines were reviewed in a session at the American Society of Health-System Pharmacists titled "Beyond the Top Line: A Point-Counterpoint Discussion of the 2020 Antimicrobial Resistant Gram-Negative Infection Treatment Guideline."
Lodise said that the panel re-convened recently to develop guidance for AmpC-bearing gram-negative pathogens. Lodise also discussed key points from the guidance, current regimen recommendations, and clinical scenarios where therapy recommendations outside of the guidelines might be considered.
